Role of PTEN in Gastrointestinal Stromal Tumor Progression

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 4, 2004, Pages 421-425

  Ricci, Riccardo ^a   Maggiano, Nicola ^a   Castri, Federica ^a   Rinelli, Alessandro ^a   Murazio, Marino ^b   Pacelli, Fabio ^a   Potenza, Angelo Eugenio ^a   Vecchio, Fabio Maria ^a   Larocca, Luigi Maria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CHROMOSOME 10; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PTEN GENE;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 10; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; KI-67 ANTIGEN; LIFE TABLES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PROPORTIONAL HAZARDS MODELS; PTEN PHOSPHOHYDROLASE; SARCOMA; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 1842426887     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fletcher CD, Berman JI, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465.
2. Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol. 2001;32:578-582.
3. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after 5TI-571. Hum Pathol. 2002;33:466-477.
4. Eisenberg BL, von Mehren M. Pharmacotherapy of gastrointestinal stromal tumours. Expert Opin Pharmacother. 2003;4:869-874.
5. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000;60:3899-3903.
6. Kim NG, Kim JJ, Ahn JY, et al. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors. Int J Cancer. 2000;85:633-638.
7. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet. 2002;70:829-844.
8. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387-390.
9. Saito T, Oda Y, Kawaguchi K, et al. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations. Int J Cancer. 2003;104:175-178.
10. Amant F, de la Rey M, Dorfling CM, et al. PTEN mutations in uterine sarcomas. Gynecol Oncol. 2002;85:165-169.
11. Lin C, Meitner PA, Terek RM. PTEN mutation is rare in chondrosarcoma. Diagn Mol Pathol. 2002;11:22-26.
12. Schneider-Stock R, Boltze C, Lasota J, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol. 2003;21:1688-1697.
13. Ricci R, Arena V, Maggiano N, et al. Role of p16INK4a in GISTs: abstracts of the 19th European Congress of Pathology, Ljubljana, Slovenia, September 6-11, 2003. Virchows Arch. 2003;443:403.
14. You MJ, Castrillon DH, Bastian BC, et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A. 2002;99:1455-1460.
15. Miettinen M, Sobin LH, Sarlomo-Rikala M, et al. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD 117 (KIT). Mod Pathol. 2000;13:1134-1142.
16. Choe G, Horvath S, Cloughesy TF, et al. Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res. 2003;63:2742-2746.
17. Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, Eng C. Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer. 2002;99:63-67.
18. Shi W, Zhang X, Pintilie M, et al. Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer. 2003;104:195-203.
19. Tachibana M, Shibakita M, Ohno S, et al. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:1955-1960.
20. Martini M, Ciccarone M, Garganese G, et al. Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis. Int J Cancer 2002;102:398-406.
21. Ginn-Pease ME, Eng C. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res. 2003;63:282-286.
22. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab. 2000;85:2334-2338.
23. Heinrich MC, Rubin BP, Longley BJ, Fletcher JA. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol. 2002;33:484-495.
24. Rubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 2001;61:8118-8121.
25. Feng LX, Ravindranath N, Dym M. Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 56 kinase pathway in spermatogonia. J Biol Chem. 2000;275:25572-25576.
26. Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH, Baker SJ. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res. 2001;61:4569-4575.